Atlas Trials

Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients

Clinical trial NCT05298670 · UNKNOWN

Trial details

NCT number
NCT05298670
Sponsor
German University in Cairo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2022-02-01
Primary completion
2023-02-28
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.